|
|
THE ROLE OF SIRTUIN 1 DEACETYLASE IN AMYOTROPHIC LATERAL SCLEROSIS |
| 5K08NS082365-03 |
HERSKOVITS, ADRIANNA ZARA |
NINDS |
2016 |
|
|
ALPHA-SYNUCLEIN BIOMARKERS IN PARKINSON DISEASE |
| 5K08NS093127-02 |
AKHTAR, RIZWAN SMEER |
NINDS |
2016 |
|
|
MECHANISMS OF C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION CAUSED NEURODEGENERATION IN ALS AND FTD |
| 5K99NS091538-02 |
SUN, SHUYING |
NINDS |
2016 |
|
|
BIOLOGY OF NATIVE ALPHA-SYNUCLEIN TETRAMERS IN PARKINSON'S DISEASE |
| 5R01NS083845-03 |
SELKOE, DENNIS J |
NINDS |
2016 |
|
|
METHODS FOR DYNAMIC CAUSAL INTERACTIONS IN HUMAN BRAIN FUNCTION AND DYSFUNCTION |
| 5R01NS086085-03 |
MENON, VINOD |
NINDS |
2016 |
|
|
AN IPSC BASED PLATFORM FOR FUNCTIONALLY ASSESSING GENETIC AND ENVIRONMENTAL RISK |
| 5R01NS088538-03 |
JAENISCH, RUDOLF |
NINDS |
2016 |
|
|
ROLE OF HLA/MHCII IN PARKINSON'S DISEASE PATHOGENESIS |
| 5R01NS092122-02 |
TANSEY, MARIA DE LOURDES G |
NINDS |
2016 |
|
|
PHASE 3 TRIAL OF INOSINE FOR PARKINSON'S DISEASE CCC |
| 5U01NS090259-02 |
SCHWARZSCHILD, MICHAEL A |
NINDS |
2016 |
